| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Outline of Final Research Achievements |
In this study, we tried to develop an immunological method to induce a stronger and more efficient cancer immunity using cytotoxic T cell receptor as a cancer immunotherapy for hepatocellular carcinoma patients.
We characterized the cancer antigen-specific cytotoxic T cells induced by peptide vaccine in hepatocellular carcinoma patients. In addition, we could obtain some candidates of cytotoxic T cell receptors useful for immunotherapy of hepatocellular carcinoma and equipped the basic informations to perform clinical studies using the cytotoxic T cell receptors.
|
